GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $14,339,000 | +31.8% | 116,845 | -6.0% | 0.05% | +4.2% |
| Q1 2020 | $10,881,000 | -13.7% | 124,255 | +3.1% | 0.05% | +14.3% |
| Q4 2019 | $12,602,000 | -72.9% | 120,524 | -70.2% | 0.04% | -73.6% |
| Q3 2019 | $46,567,000 | -54.0% | 404,829 | -31.1% | 0.16% | -51.7% |
| Q2 2019 | $101,295,000 | +3.8% | 587,590 | +1.5% | 0.33% | +1.2% |
| Q1 2019 | $97,574,000 | +87.9% | 578,832 | +8.5% | 0.32% | +71.1% |
| Q4 2018 | $51,940,000 | -52.5% | 533,323 | -15.8% | 0.19% | -37.3% |
| Q3 2018 | $109,428,000 | +1.7% | 633,484 | -17.9% | 0.30% | -3.8% |
| Q2 2018 | $107,614,000 | +464.0% | 771,206 | +436.5% | 0.32% | +443.1% |
| Q3 2016 | $19,081,000 | +89.4% | 143,758 | +53.1% | 0.06% | +427.3% |
| Q2 2014 | $10,076,000 | +296.2% | 93,918 | +119.3% | 0.01% | +83.3% |
| Q1 2014 | $2,543,000 | – | 42,828 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |